WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$69.96
+1.92%Forward multiples
Based on analyst estimates
- P/E forward
- 80.97x
- P/E 2026E
- 683.05x
- P/E 2027E
- 56.98x
- P/E 2028E
- 38.37x
- P/S forward
- 3.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.54x
- Price / sales
- 4.59x
- Price / cash flow
- -42.83x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 4.67x
- EV / EBITDA
- -27.75x
- EV / EBIT
- -35.00x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026